Also, defective GC signaling, due to decreased ligand production and/or GR levels, has been reported in the skin of patients or mouse models with inflammatory skin disease [14–17]; however, whether this is a consequence of or a contributing factor to pathology is unclear. Here, NR3C1 is linked to inflammatory skin disease.